Literature DB >> 23389852

A mouse model of chronic prostatic inflammation using a human prostate cancer-derived isolate of Propionibacterium acnes.

Debika Biswal Shinohara1, Ajay M Vaghasia, Shu-Han Yu, Tim N Mak, Holger Brüggemann, William G Nelson, Angelo M De Marzo, Srinivasan Yegnasubramanian, Karen S Sfanos.   

Abstract

BACKGROUND: Prostatic inflammation has been linked to a number of prostatic diseases such as benign prostatic hyperplasia (BPH), prostatitis syndromes, and prostate cancer. Major unanswered questions include what pathogenic mechanisms, such as bacterial infections, may drive the accumulation of inflammatory infiltrates in the human prostate, and how inflammation might contribute to disease. To study this potential link in an in vivo system, we developed a mouse model of long-term bacteria-induced chronic inflammation of the prostate using a human prostatectomy-derived strain of Propionibacterium acnes.
METHODS: C57BL/6J mice were inoculated, via urethral catheterization, with vehicle control or a prostatectomy-derived strain of P. acnes (PA2). Animals were assessed at 2 days, 1, 2, or 8 weeks post-inoculation via histology and immunohistochemistry (IHC).
RESULTS: PA2 inoculation resulted in severe acute and chronic inflammation confined to the dorsal lobe of the prostate. Chronic inflammation persisted for at least 8 weeks post-inoculation. Inflammatory lesions were associated with an increase in the Ki-67 proliferative index, and diminished Nkx3.1 and androgen receptor (AR) production. Interestingly, the observed response required live bacteria and both IHC and in situ hybridization assays for P. acnes indicated a potential intracellular presence of P. acnes in prostate epithelial cells.
CONCLUSIONS: To our knowledge, this is the first mouse model of long-term prostatic inflammation induced by P. acnes, and more generally, any prostatectomy-derived bacterial isolate. This model may serve as a valuable preclinical model of chronic prostatic inflammation that can be used to mechanistically study the link between inflammation and prostatic disease.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2013        PMID: 23389852      PMCID: PMC3991131          DOI: 10.1002/pros.22648

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  34 in total

1.  Acne in adolescence and cause-specific mortality: lower coronary heart disease but higher prostate cancer mortality: the Glasgow Alumni Cohort Study.

Authors:  B Galobardes; G Davey Smith; M Jeffreys; S Kinra; P McCarron
Journal:  Am J Epidemiol       Date:  2005-06-15       Impact factor: 4.897

2.  Acute bacterial inflammation of the mouse prostate.

Authors:  Bayli J Boehm; Sara A Colopy; Travis J Jerde; Christopher J Loftus; Wade Bushman
Journal:  Prostate       Date:  2011-06-16       Impact factor: 4.104

3.  Loss of Nkx3.1 expression in bacterial prostatitis: a potential link between inflammation and neoplasia.

Authors:  May Khalili; Laura N Mutton; Bora Gurel; Jessica L Hicks; Angelo M De Marzo; Charles J Bieberich
Journal:  Am J Pathol       Date:  2010-04-02       Impact factor: 4.307

Review 4.  Experimental rodent models of prostatitis: limitations and potential.

Authors:  E V Vykhovanets; M I Resnick; G T MacLennan; S Gupta
Journal:  Prostate Cancer Prostatic Dis       Date:  2007-01-02       Impact factor: 5.554

5.  Impacts of antibiotic and anti-inflammatory therapies on serum prostate-specific antigen levels in the presence of prostatic inflammation: a prospective randomized controlled trial.

Authors:  Ozgur Ugurlu; Mehmet Yaris; C Volkan Oztekin; T Murat Kosan; Oztug Adsan; Mesut Cetinkaya
Journal:  Urol Int       Date:  2010-03-04       Impact factor: 2.089

6.  Cytotoxic necrotizing factor type 1-positive Escherichia coli causes increased inflammation and tissue damage to the prostate in a rat prostatitis model.

Authors:  K E Rippere-Lampe; M Lang; H Ceri; M Olson; H A Lockman; A D O'Brien
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

7.  Acute inflammation promotes early cellular stimulation of the epithelial and stromal compartments of the rat prostate.

Authors:  Amado A Quintar; Andreas Doll; Carolina Leimgruber; Claudia M Palmeri; Felix D Roth; Mariana Maccioni; Cristina A Maldonado
Journal:  Prostate       Date:  2010-08       Impact factor: 4.104

8.  Decreased NKX3.1 protein expression in focal prostatic atrophy, prostatic intraepithelial neoplasia, and adenocarcinoma: association with gleason score and chromosome 8p deletion.

Authors:  Carlise R Bethel; Dennis Faith; Xiang Li; Bin Guan; Jessica L Hicks; Fusheng Lan; Robert B Jenkins; Charles J Bieberich; Angelo M De Marzo
Journal:  Cancer Res       Date:  2006-11-15       Impact factor: 12.701

9.  Successful immunotherapy with intraperitoneal Corynebacterium parvum in a murine ovarian cancer model is associated with the recruitment of tumor-lytic neutrophils into the peritoneal cavity.

Authors:  A K Lichtenstein; J Kahle; J Berek; J Zighelboim
Journal:  J Immunol       Date:  1984-07       Impact factor: 5.422

10.  Aggressiveness of inflammation in histological prostatitis--correlation with total and free prostate specific antigen levels in men with biochemical criteria for prostate biopsy.

Authors:  G Stimac; A Reljic; B Spajic; J Dimanovski; B Ruzic; M Ulamec; Z Sonicki; O Kraus
Journal:  Scott Med J       Date:  2009-08       Impact factor: 0.729

View more
  47 in total

Review 1.  The inflammatory microenvironment and microbiome in prostate cancer development.

Authors:  Karen S Sfanos; Srinivasan Yegnasubramanian; William G Nelson; Angelo M De Marzo
Journal:  Nat Rev Urol       Date:  2017-10-31       Impact factor: 14.432

Review 2.  Human microbiome and prostate cancer development: current insights into the prevention and treatment.

Authors:  Solmaz Ohadian Moghadam; Seyed Ali Momeni
Journal:  Front Med       Date:  2020-06-30       Impact factor: 4.592

Review 3.  Collateral damage: insights into bacterial mechanisms that predispose host cells to cancer.

Authors:  Aurélie Gagnaire; Bertrand Nadel; Didier Raoult; Jacques Neefjes; Jean-Pierre Gorvel
Journal:  Nat Rev Microbiol       Date:  2017-01-03       Impact factor: 60.633

Review 4.  Propionibacterium acnes: from commensal to opportunistic biofilm-associated implant pathogen.

Authors:  Yvonne Achermann; Ellie J C Goldstein; Tom Coenye; Mark E Shirtliff
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

5.  The common parasite Toxoplasma gondii induces prostatic inflammation and microglandular hyperplasia in a mouse model.

Authors:  Darrelle L Colinot; Tamila Garbuz; Maarten C Bosland; Liang Wang; Susan E Rice; William J Sullivan; Gustavo Arrizabalaga; Travis J Jerde
Journal:  Prostate       Date:  2017-05-12       Impact factor: 4.104

6.  Inflammation promotes prostate differentiation.

Authors:  Xian Liu; Andrew S Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-23       Impact factor: 11.205

7.  A human prostatic bacterial isolate alters the prostatic microenvironment and accelerates prostate cancer progression.

Authors:  Brian W Simons; Nicholas M Durham; Tullia C Bruno; Joseph F Grosso; Anthony J Schaeffer; Ashley E Ross; Paula J Hurley; David M Berman; Charles G Drake; Praveen Thumbikat; Edward M Schaeffer
Journal:  J Pathol       Date:  2015-02       Impact factor: 7.996

8.  Sex differences in IL-17 contribute to chronicity in male versus female urinary tract infection.

Authors:  Anna Zychlinsky Scharff; Matthieu Rousseau; Livia Lacerda Mariano; Tracy Canton; Camila Rosat Consiglio; Matthew L Albert; Magnus Fontes; Darragh Duffy; Molly A Ingersoll
Journal:  JCI Insight       Date:  2019-05-30

9.  Infections and inflammation in prostate cancer.

Authors:  Karen S Sfanos; William B Isaacs; Angelo M De Marzo
Journal:  Am J Clin Exp Urol       Date:  2013-12-25

10.  Cultivable internal bacterial flora of ticks isolated in Hungary.

Authors:  László Egyed; László Makrai
Journal:  Exp Appl Acarol       Date:  2013-12-24       Impact factor: 2.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.